SCHEMBL14318134

SCHEMBL14318134

P=Cc1c[nH]c2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.64
▸ IMPDH2 P12268 1/20 0.64
▸ HPGD P15428 3/20 0.58
▸ HTT P42858 1/20 0.58
▸ APP P05067 1/20 0.53
▸ SENP7 Q9BQF6 1/20 0.50
▸ MAPT P10636 5/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ PTGS2 P35354 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ HSP90AA1 P07900 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27821745 0.82 CYP2A6 (0.69) CYP2A6IMPDH2HPGDHTTAPP
SCHEMBL10489040 0.82 CYP2A6 (0.69) CYP2A6IMPDH2HPGDHTTAPP
SCHEMBL29467928 0.78 CYP2A6 (0.64) CYP2A6IMPDH2HPGDHTTAPP
SCHEMBL13759052 0.78 CYP2A6 (0.64) CYP2A6IMPDH2HPGDHTTAPP
3-Formylindole SCHEMBL30782674 0.78 CYP2A6 (1.00) CYP2A6IMPDH2HPGDHTTAPP
3-Formylindole SCHEMBL38654556 0.78 CYP2A6 (1.00) CYP2A6IMPDH2HPGDHTTAPP
3-Formylindole SCHEMBL19180195 0.78 CYP2A6 (0.70) CYP2A6IMPDH2HPGDHTTAPP
SCHEMBL79559 0.78 CYP2A6 (0.64) CYP2A6IMPDH2HPGDHTTAPP
3-Formylindole SCHEMBL56373 0.78 CYP2A6 (1.00) CYP2A6IMPDH2HPGDHTTAPP
SCHEMBL315329 0.78 CYP2A6 (0.64) CYP2A6IMPDH2HPGDHTTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012171337-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-12-20 — — WO disclosed
Send feedback